8,699
Views
1
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

, , , , , , , , , , , , & show all
Pages 1395-1405 | Received 19 Jul 2023, Accepted 10 Aug 2023, Published online: 29 Aug 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.